MXEBX
Price
$16.96
Change
-$0.15 (-0.88%)
Updated
Sep 5 closing price
Net Assets
690.1M
VTSMX
Price
$155.50
Change
-$0.31 (-0.20%)
Updated
Sep 5 closing price
Net Assets
1.95T
Interact to see
Advertisement

MXEBX vs VTSMX

Header iconMXEBX vs VTSMX Comparison
Open Charts MXEBX vs VTSMXBanner chart's image
Empower Core Strategies US Eq Instl
Price$16.96
Change-$0.15 (-0.88%)
VolumeN/A
Net Assets690.1M
Vanguard Total Stock Mkt Idx I
Price$155.50
Change-$0.31 (-0.20%)
VolumeN/A
Net Assets1.95T
MXEBX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MXEBX vs. VTSMX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEBX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.95T vs. MXEBX (690M). MXEBX pays higher dividends than VTSMX: MXEBX (1.52) vs VTSMX (1.07). MXEBX was incepted earlier than VTSMX: MXEBX (7 years) vs VTSMX (33 years). MXEBX (0.71) is less costly to investors than VTSMX (0.14). MXEBX is a more actively managed with annual turnover of: 20.00 vs. VTSMX (2.00). MXEBX has a lower initial minimum investment than VTSMX: MXEBX (0) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 18.03 vs. MXEBX (8.56). VTSMX return over 5 years is better than : 84.94 vs. MXEBX (60.19).
MXEBXVTSMXMXEBX / VTSMX
Total Expense Ratio0.550.14393%
Annual Report Gross Expense Ratio0.710.14507%
Fund Existence7 years33 years-
Gain YTD9.64910.33093%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets690M1.95T0%
Annual Yield % from dividends1.521.07142%
Returns for 1 year8.5618.0348%
Returns for 3 years53.8563.6385%
Returns for 5 years60.1984.9471%
Returns for 10 yearsN/A224.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO53.381.55
+2.99%
BridgeBio Pharma
INBX28.180.46
+1.66%
Inhibrx Biosciences Inc.
MAN41.26-0.05
-0.12%
ManpowerGroup
CNVS3.71-0.07
-1.85%
Cineverse Corp
UPC3.55-0.18
-4.83%
Universe Pharmaceuticals Inc